Molecular biology and therapeutics · BEGINNER LESSON
ASO
An antisense oligonucleotide (ASO) is a short, synthetic single-stranded nucleic acid that binds a chosen RNA by base pairing. Depending on its chemistry and binding site, it can reduce RNA levels or block RNA processing without changing the genome.
What ASOs are and what is measured
ASOs are short, synthetic nucleic acid polymers, usually single-stranded, designed to bind a specific RNA sequence. In practice, what is measured is their effect on the target RNA: whether the RNA is degraded, whether translation is blocked, or whether pre-mRNA splicing is changed. ASOs are studied as medicines because they can regulate gene expression at the RNA level rather than adding a new gene copy. [0,1,2]
[1] Oligonucleotides-Based Therapeutics [2] 3. Antisense Oligonucleotide... [3] The Challenges and Strategies of Antisense Oligonucleotide Drug ...
How they work
After an ASO base-pairs with its target RNA, two main mechanisms are possible. In one, the ASO acts through steric hindrance: it physically blocks ribosomes, splicing factors, or other RNA-binding machinery from using the RNA. In the other, the ASO recruits RNase H1, an enzyme that cuts the RNA strand in an RNA-DNA duplex, leading to RNA degradation. Different chemical designs favor different effects, such as transcript knockdown or splice switching. [0,1,2]
[1] Oligonucleotides-Based Therapeutics [2] 3. Antisense Oligonucleotide... [3] The Challenges and Strategies of Antisense Oligonucleotide Drug ...
Why chemistry and delivery matter
ASOs often include chemical modifications that improve binding to RNA and resistance to nuclease enzymes, which are enzymes that break down nucleic acids. Examples in the sources include 2′-O-methyl and 2′-O-methoxyethyl modifications, and phosphorothioate-linked designs. Even with these improvements, ASOs are large, polar molecules that do not cross cell membranes or biological barriers easily, so delivery and route of administration must be optimized. Their effects are also temporary because they do not change the genome. [0,1,2]
[1] Oligonucleotides-Based Therapeutics [2] 3. Antisense Oligonucleotide... [3] The Challenges and Strategies of Antisense Oligonucleotide Drug ...
Limitations
Important limits include poor delivery to intracellular targets, possible toxicity, immune activation, and off-target effects. Off-target effects can happen when an ASO binds a partially matching RNA and causes unwanted degradation or splicing changes. The sources also note that some ASO effects wear off as the molecules are degraded or diluted during cell turnover, so repeated dosing is often needed. [0,1,2]
[1] Oligonucleotides-Based Therapeutics [2] 3. Antisense Oligonucleotide... [3] The Challenges and Strategies of Antisense Oligonucleotide Drug ...
SEE THE IDEA
How an ASO can change gene expression
A short synthetic strand is made to match one RNA sequence.
The ASO base-pairs with its target RNA.
It can block RNA machinery or recruit RNase H1 to cut the RNA.
The target RNA is reduced or processed differently, changing gene expression.
Design leads to RNA binding, which then triggers either blocking or RNA cleavage, producing a change in RNA behavior.
ASOs act at the RNA level; the same general class can silence transcripts or alter splicing depending on design and target site.
TRY IT YOURSELF
Test your understanding
Choose an answer, then check the explanation.
PUT IT TOGETHER
Match each concept to its meaning
Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.
4 pairs to match
Sources and further reading
This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.